In view of the enormous harm of hypoglycemia, medical staff will be more cautious when using CVII compared with subcutaneous insulin in patients, selecting more conservative pump rates and doses to maintain the blood glucose at a higher level within the normal range and avoid the occurrence of hypoglycemia as much as possible. Here, INS is linked to Hypoglycemia.